Search Results - Fuente A.
- Showing 1 - 3 results of 3
-
1
-
2
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum] by Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J
Published in ClinicoEconomics and Outcomes Research (2021-07-01)Get full text
Article -
3
NIKA2 observations of starless cores in Taurus and Perseus by Kramer C., Adam R., Ade P., Ajeddig H., André P., Artis E., Aussel H., Beelen A., Benoît A., Berta S., Bing L., Bourrion O., Calvo M., Caselli P., Catalano A., De Petris M., Désert F.-X., Doyle S., Driessen E.F.C., Ejlali G., Fuente A., Gomez A., Goupy J., Hanser C., Katsioli S., Kéruzoré F., Ladjelate B., Lagache G., Leclercq S., Lestrade J.-F., Macías-Pérez J. F., Madden S.C., Maury A., Mauskopf P., Mayet F., Monfardini A., Moyer-Anin A., Muñoz-Echeverría M., Navarro-Almaida D., Perotto L., Pisano G., Ponthieu N., Revéret V., Rigby A.J., Ritacco A., Romero C., Roussel H., Ruppin F., Schuster K., Sievers A., Tucker C., Zylka R.
Published in EPJ Web of Conferences (2024-01-01)Get full text
Article
